Stephen H. Lockhart's most recent trade in Molina Healthcare Inc was a trade of 180 Common Stock done at an average price of $306.3 . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 306.29 per share. | 01 Jul 2025 | 180 | 3,140 (0%) | 0% | 306.3 | 55,132 | Common Stock |
| National Research Corp | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 34,917 | 34,917 | - | - | Director Stock Option (Right to Buy) | |
| West Pharma Services | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 1,071 | 2,708 (0%) | 0% | 0 | Common Stock | |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 327.71 per share. | 01 Apr 2025 | 168 | 2,960 (0%) | 0% | 327.7 | 55,055 | Common Stock |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 291.05 per share. | 01 Jan 2025 | 189 | 2,792 (0%) | 0% | 291.0 | 55,008 | Common Stock |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 341.91 per share. | 01 Oct 2024 | 161 | 2,603 (0%) | 0% | 341.9 | 55,048 | Common Stock |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 292.16 per share. | 01 Jul 2024 | 188 | 2,442 (0%) | 0% | 292.2 | 54,926 | Common Stock |
| National Research Corp | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 10,906 | 10,906 | - | - | Director Stock Option (Right to Buy) | |
| West Pharma Services | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2024 | 564 | 1,634 (0%) | 0% | 0 | Common Stock | |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 404.20 per share. | 01 Apr 2024 | 136 | 2,254 (0%) | 0% | 404.2 | 54,971 | Common Stock |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 361.31 per share. | 01 Jan 2024 | 152 | 2,118 (0%) | 0% | 361.3 | 54,919 | Common Stock |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 327.89 per share. | 01 Oct 2023 | 168 | 1,966 (0%) | 0% | 327.9 | 55,086 | Common Stock |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 301.24 per share. | 01 Jul 2023 | 183 | 1,798 (0%) | 0% | 301.2 | 55,127 | Common Stock |
| National Research Corp | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 7,386 | 7,386 | - | - | Director Stock Option (Right to Buy) | |
| West Pharma Services | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 616 | 1,070 (0%) | 0% | - | Common Stock | |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 267.49 per share. | 01 Apr 2023 | 206 | 1,615 (0%) | 0% | 267.5 | 55,103 | Common Stock |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 330.22 per share. | 01 Jan 2023 | 167 | 1,409 (0%) | 0% | 330.2 | 55,147 | Common Stock |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 329.84 per share. | 01 Oct 2022 | 167 | 1,242 (0%) | 0% | 329.8 | 55,083 | Common Stock |
| West Pharma Services | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 454 | 454 (0%) | 0% | - | Common Stock | |
| National Research Corp | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 12,078 | 12,078 | - | - | Director Stock Option (Right to Buy) | |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 339.41 per share. | 01 Apr 2022 | 162 | 881 (0%) | 0% | 339.4 | 54,984 | Common Stock |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 318.08 per share. | 01 Jan 2022 | 173 | 719 (0%) | 0% | 318.1 | 55,028 | Common Stock |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 271.51 per share. | 01 Oct 2021 | 203 | 546 (0%) | 0% | 271.5 | 55,117 | Common Stock |
| Molina Healthcare | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 256.05 per share. | 01 Jul 2021 | 215 | 343 (0%) | 0% | 256.1 | 55,051 | Common Stock |
| National Research Corp | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 7,289 | 7,289 | - | - | Director Stock Option (Right to Buy) | |
| National Research Corp | Stephen H. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,822 | 6,822 | - | - | Director Stock Option (Right to Buy) |